Targeting Non-Homologous End-Joining Through Epidermal Growth Factor Receptor Inhibition: Rationale and Strategies for Radiosensitization
Membrane-bound wild type EGFR is activated after binding its ligands: epidermal growth factor (EGF) or transforming growth factor-α (TGF-α). The three domains of EGFR are highlighted with brackets: i (ligand-binding domain), ii (transmembrane domain), and iii (tyrosine kinase domain or TKD). Activated EGFR signals through the following pathways: 1) phosphatidylinositol 3-kinase (PI3K)-Akt-1 pathway, 2) Ras/RAF/mitogen-activated protein kinase (MAPK)/extracellular signal regulated (ERK) pathway, and 3) signal transducer and activation of transcription (STAT) pathway (only the PI3K-Akt-1 pathway is shown for simplicity). The two commonest categories of mutations observed in EGFR are: 1) Somatic “gain-of-function” mutations in the TKD, seen prominently in lung cancers (not shown), and 2) deletion mutations in the extracellular domain, seen commonly in brain cancers (EGFRvIII). EGFRvIII is constitutively active and signals preferentially via the PI3K-Akt-1 pathway. In this pathway, activated phosphatidylinositol kinase (PI3K) phosphorylates phosphatidylinositol-4,5-biphosphate (PIP2) to generate phosphatidylinositol-3,4,5-triphosphate (PIP3). PIP3 anchors Akt-1 to the plasma membrane, where it is phosphorylated by mTOR complex 2 (mTORC2) and 3-phosphoinositide-dependent kinase 1 (PDK1). Activated Akt-1 phosphorylates a plethora of downstream targets resulting in enhanced proliferation and decreased cell death. The PTEN tumor suppressor reverses PIP3 back to PIP2, negatively regulating PI3K-Akt-1 signaling. In response to ionizing radiation (IR), wild type EGFR can translocate into the nucleus and interact with DNA-PKcs (DNA-dependent protein kinase, catalytic subunit) stimulating its DNA repair activity (I). However, EGFR with somatic mutations in the TKD is defective in nuclear translocation and has a radiosensitizing effect (not shown). PI3K-Akt-1 signaling triggered by EGFR or EGFRvIII can also promote DSB repair (II). In response to IR, Akt-1 translocates into the nucleus and interacts with DNA-PKcs. DNA-PKcs phosphorylates Akt-1 in response to IR promoting survival (curved arrow) and we speculate that reciprocal phosphorylation of DNA-PKcs by Akt-1 (?) might promote DSB repair by NHEJ. As EGFR signaling promotes NHEJ, inhibitors of EGFR and Akt-1 can serve as effective radiosensitizers.
Publication
Targeting Non-Homologous End-Joining Through Epidermal Growth Factor Receptor Inhibition: Rationale and Strategies for Radiosensitization. () Bipasha Mukherjee, et al. Semin Radiat Oncol. ;20(4):250-257. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | EGF | EGF | ncbigene_symbol | EGF | 1950 |
| Homo sapiens | Primates | TGF-a | TGFA | ncbigene_symbol | TGFA | 7039 |
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | P13K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | P13K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | P13K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | P13K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | P13K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | P13K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | P13K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | P13K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | P13K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | P13K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | DNA-PK | DNAPK | ncbigene_synonym | PRKDC | 5591 |
| Homo sapiens | Primates | PDK1 | PDK1 | ncbigene_symbol | PDK1 | 5163 |
| Homo sapiens | Primates | PDK1 | PDK1 | ncbigene_synonym | PDPK1 | 5170 |
| Mus musculus | Rodents | EGF | EGF | ncbigene_symbol | Egf | 13645 |
| Mus musculus | Rodents | TGF-a | TGFA | ncbigene_symbol | Tgfa | 21802 |
| Mus musculus | Rodents | EGFR | EGFR | ncbigene_symbol | Egfr | 13649 |
| Mus musculus | Rodents | P13K | PI3K | ncbigene_synonym | Pik3r1 | 18708 |
| Mus musculus | Rodents | PTEN | PTEN | ncbigene_symbol | Pten | 19211 |
| Mus musculus | Rodents | AKT | AKT | ncbigene_synonym | Akt1 | 11651 |
| Mus musculus | Rodents | DNA-PK | DNAPK | ncbigene_synonym | Prkdc | 19090 |
| Mus musculus | Rodents | PDK1 | PDK1 | ncbigene_symbol | Pdk1 | 228026 |
| Mus musculus | Rodents | PDK1 | PDK1 | ncbigene_synonym | Pdpk1 | 18607 |
| Drosophila melanogaster | Invertebrates | EGF | EGF | ncbigene_synonym | Egfr | 37455 |
| Drosophila melanogaster | Invertebrates | P13K | PI3K | ncbigene_synonym | Pi3K21B | 33203 |
| Drosophila melanogaster | Invertebrates | P13K | PI3K | ncbigene_synonym | Pi3K59F | 37733 |
| Drosophila melanogaster | Invertebrates | P13K | PI3K | ncbigene_synonym | Pi3K68D | 39329 |
| Drosophila melanogaster | Invertebrates | P13K | PI3K | ncbigene_synonym | Pi3K92E | 42446 |
| Drosophila melanogaster | Invertebrates | PTEN | PTEN | ncbigene_symbol | Pten | 43991 |
| Drosophila melanogaster | Invertebrates | AKT | AKT | ncbigene_symbol | Akt | 41957 |
| Drosophila melanogaster | Invertebrates | DSB | DSB | ncbigene_symbol | dsb | 38252 |
| Drosophila melanogaster | Invertebrates | PDK1 | PDK1 | ncbigene_symbol | Pdk1 | 38017 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA |